ChenGuang Biotech Group Past Earnings Performance
Past criteria checks 1/6
ChenGuang Biotech Group has been growing earnings at an average annual rate of 12.3%, while the Food industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 17.1% per year. ChenGuang Biotech Group's return on equity is 3.7%, and it has net margins of 2.2%.
Key information
12.3%
Earnings growth rate
10.9%
EPS growth rate
| Food Industry Growth | 7.2% |
| Revenue growth rate | 17.1% |
| Return on equity | 3.7% |
| Net Margin | 2.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How ChenGuang Biotech Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 6,927 | 150 | -14 | 11 |
| 30 Jun 24 | 6,694 | 287 | -1 | 10 |
| 31 Mar 24 | 6,786 | 389 | -4 | 5 |
| 31 Dec 23 | 6,872 | 486 | 0 | 0 |
| 30 Sep 23 | 6,669 | 496 | 226 | 92 |
| 30 Jun 23 | 6,737 | 492 | 237 | 113 |
| 31 Mar 23 | 6,529 | 462 | 243 | 129 |
| 31 Dec 22 | 6,296 | 434 | 249 | 129 |
| 30 Sep 22 | 6,465 | 429 | 255 | 135 |
| 30 Jun 22 | 6,002 | 403 | 244 | 116 |
| 31 Mar 22 | 5,446 | 380 | 228 | 99 |
| 31 Dec 21 | 4,874 | 352 | 211 | 95 |
| 30 Sep 21 | 4,410 | 322 | 190 | 88 |
| 30 Jun 21 | 4,186 | 304 | 189 | 91 |
| 31 Mar 21 | 4,188 | 285 | 165 | 83 |
| 01 Jan 21 | 3,913 | 268 | 192 | 83 |
| 30 Sep 20 | 3,667 | 252 | 211 | 68 |
| 30 Jun 20 | 3,481 | 235 | 231 | 48 |
| 31 Mar 20 | 3,288 | 206 | 281 | 52 |
| 31 Dec 19 | 3,265 | 194 | 269 | 49 |
| 30 Sep 19 | 3,226 | 165 | 272 | 45 |
| 30 Jun 19 | 3,378 | 162 | 254 | 43 |
| 31 Mar 19 | 3,139 | 146 | 232 | 34 |
| 01 Jan 19 | 3,063 | 145 | 218 | 29 |
| 30 Sep 18 | 2,799 | 155 | 187 | 26 |
| 30 Jun 18 | 2,779 | 159 | 153 | 42 |
| 31 Mar 18 | 2,807 | 155 | 140 | 35 |
| 31 Dec 17 | 2,772 | 143 | 152 | 29 |
| 30 Sep 17 | 2,780 | 129 | 189 | 21 |
| 30 Jun 17 | 2,384 | 120 | 209 | 0 |
| 31 Mar 17 | 2,259 | 111 | 211 | 0 |
| 31 Dec 16 | 2,141 | 92 | 191 | 0 |
| 30 Sep 16 | 1,824 | 99 | 141 | 0 |
| 30 Jun 16 | 1,636 | 79 | 122 | 0 |
| 31 Mar 16 | 1,474 | 80 | 109 | 0 |
| 31 Dec 15 | 1,268 | 69 | 100 | 0 |
| 30 Sep 15 | 1,246 | 59 | 97 | 0 |
| 30 Jun 15 | 1,287 | 57 | 96 | 0 |
| 31 Mar 15 | 1,205 | 24 | 95 | 0 |
| 31 Dec 14 | 1,207 | 22 | 92 | 0 |
| 30 Sep 14 | 1,238 | 21 | 88 | 0 |
| 30 Jun 14 | 1,174 | 4 | 90 | 0 |
| 31 Mar 14 | 1,131 | 3 | 99 | 0 |
| 31 Dec 13 | 1,186 | 10 | 103 | 0 |
Quality Earnings: 300138 has a large one-off loss of CN¥91.3M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 300138's current net profit margins (2.2%) are lower than last year (7.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300138's earnings have grown by 12.3% per year over the past 5 years.
Accelerating Growth: 300138's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300138 had negative earnings growth (-69.8%) over the past year, making it difficult to compare to the Food industry average (-5.8%).
Return on Equity
High ROE: 300138's Return on Equity (3.7%) is considered low.